Evaluation of plasma Aβ40 and Aβ42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment
To access this article, please choose from the options below
PII: S0197-4580(08)00131-0
doi:10.1016/j.neurobiolaging.2008.03.027
© 2008 Elsevier Inc. All rights reserved.
